Liesbeth DeLange, PhD
Principal Investigator, Predictive Pharmacology, Division of Systems Biomedicine and Pharmacology, Leiden Academic Center for Drug Research, Leiden University, The Netherlands
Malcolm McCoss, PhD, FRSC
Visiting Professor of Chemistry for Medicine, University of Oxford, Oxford, UK and Founder, Bohicket Pharma Consulting, LLC
David Witty, PhD
Vice President of Chemistry and IP, Eliem Therapeutics; Co-Founder and Director, WITNET, Ltd
